AVNS Q4 2023 Earnings — Avanos Medical, Inc. Revenue & Financial Results | Market Cap Arena

AVNSAvanos Medical, Inc.

$621M

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$173M-4.6% YoY

Gross Profit

$95M54.8% margin

Operating Income

$22M12.8% margin

Net Income

$11M6.1% margin

EPS (Diluted)

$0.23

QoQ Revenue Growth

+1.2%

Cash Flow

Operating Cash Flow

$13M

Free Cash Flow

$7M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$456M

Stockholders' Equity

$1.2B

Cash & Equivalents

$88M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$173M	$182M	-4.6%
Gross Profit	$95M	$103M	-7.7%
Operating Income	$22M	$17M	+27.6%
Net Income	$11M	$17M	-37.9%

Revenue Segments

Digestive Health

$184M100%